$HLGN
Heliogen, Inc. Stock $hlgn

$hlgn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000184029224000022 Filed on May 08, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$2.261M	$1.528M
YoY Change	62.2%	-21.12%
Cost Of Revenue	$3.929M	$1.477M
YoY Change	158.15%	-37.99%
Gross Profit	-$1.668M	$51.00K
YoY Change	1203.13%	-111.46%
Gross Profit Margin	-73.77%	3.34%
Selling, General & Admin	$9.505M	$12.39M
YoY Change	-46.15%	197.41%
% of Gross Profit		24288.24%
Research & Development	$4.751M	$3.791M
YoY Change	-3.94%	-27.93%
% of Gross Profit		7433.33%
Depreciation & Amortization	$300.0K	$446.0K
YoY Change	-50.0%	-25.79%
% of Gross Profit		874.51%
Operating Expenses	$18.38M	$16.18M
YoY Change	-18.65%	55.07%
Operating Profit	-$20.05M	-$16.13M
YoY Change	-11.77%	48.25%
Interest Expense	$675.0K	$683.0K
YoY Change	150.0%	141.34%
% of Operating Profit
Other Income/Expense, Net	$52.00K	$245.0K
YoY Change	-93.71%	-196.84%
Pretax Income	-$19.28M	-$15.22M
YoY Change	-11.07%	44.38%
Income Tax	$2.000K	$2.000K
% Of Pretax Income
Net Earnings	-$19.28M	-$15.23M
YoY Change	-11.07%	44.39%
Net Earnings / Revenue	-852.81%	-996.4%
Basic Earnings Per Share	-$3.19	-$2.53
Diluted Earnings Per Share	-$3.19	-$2.53
COMMON SHARES
Basic Shares Outstanding	5.970M shares	5.970M shares
Diluted Shares Outstanding	6.045M shares	6.021M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.84M	$60.73M
YoY Change	-51.91%	-49.36%
Cash & Equivalents	$51.84M	$58.20M
Short-Term Investments	$0.00	$2.491M
Other Short-Term Assets	$2.981M	$2.878M
YoY Change	-34.02%	-48.79%
Inventory	$0.00	$1.823M
Prepaid Expenses
Receivables	$4.028M	$6.002M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$58.85M	$71.43M
YoY Change	-51.94%	-48.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.243M	$5.332M
YoY Change	-80.66%	-21.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.508M	$1.582M
YoY Change	-69.88%	-80.48%
Total Long-Term Assets	$10.44M	$21.50M
YoY Change	-66.83%	-30.41%
TOTAL ASSETS
Total Short-Term Assets	$58.85M	$71.43M
Total Long-Term Assets	$10.44M	$21.50M
Total Assets	$69.29M	$92.93M
YoY Change	-54.98%	-45.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.403M	$1.172M
YoY Change	66.04%	-64.32%
Accrued Expenses	$9.015M	$8.216M
YoY Change	-7.86%	38.2%
Deferred Revenue	$19.26M	$18.25M
YoY Change	57.25%	66.4%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$104.4M	$102.2M
YoY Change	107.32%	110.38%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$149.0K	$194.0K
YoY Change	-91.09%	-87.6%
Total Long-Term Liabilities	$149.0K	$194.0K
YoY Change	-91.09%	-87.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$104.4M	$102.2M
Total Long-Term Liabilities	$149.0K	$194.0K
Total Liabilities	$109.8M	$114.8M
YoY Change	67.33%	79.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$472.7M	-$453.4M
YoY Change	38.7%	42.08%
Common Stock	$1.000K	$1.000K
YoY Change	-95.0%	-94.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$40.48M	-$21.92M
YoY Change
Total Liabilities & Shareholders Equity	$69.29M	$92.93M
YoY Change	-54.98%	-45.33%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$19.28M	-$15.23M
YoY Change	-11.07%	44.39%
Depreciation, Depletion And Amortization	$300.0K	$446.0K
YoY Change	-50.0%	-25.79%
Cash From Operating Activities	-$9.285M	-$14.30M
YoY Change	-34.73%	-40.74%
INVESTING ACTIVITIES
Capital Expenditures	$74.00K	$150.0K
YoY Change	-77.37%	-71.54%
Acquisitions
YoY Change
Other Investing Activities	$2.961M	$10.00M
YoY Change	-82.82%	-43.76%
Cash From Investing Activities	$2.887M	$9.850M
YoY Change	-82.92%	-42.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.000K	-$17.00K
YoY Change	-99.81%	-106.85%
NET CHANGE
Cash From Operating Activities	-9.285M	-$14.30M
Cash From Investing Activities	2.887M	$9.850M
Cash From Financing Activities	2.000K	-$17.00K
Net Change In Cash	-6.396M	-$4.480M
YoY Change	-270.33%	-32.44%
FREE CASH FLOW
Cash From Operating Activities	-$9.285M	-$14.30M
Capital Expenditures	$74.00K	$150.0K
Free Cash Flow	-$9.359M	-$14.45M
YoY Change	-35.69%	-41.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001840292
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5970373	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58235000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62715000	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	2491000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	12386000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	6002000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1956000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2378000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1230000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	71429000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	83466000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13583000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13909000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5332000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5577000	usd
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	4679000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1823000	usd
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0286
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0286
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0286
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P2Y9M
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1000000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1000000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1582000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3081000	usd
CY2024Q1	us-gaap	Assets Assets	92926000	usd
CY2023Q4	us-gaap	Assets Assets	107033000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1172000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	746000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8216000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8907000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18247000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	17008000	usd
CY2024Q1	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	74516000	usd
CY2023Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	75340000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	102151000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	102001000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12502000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12878000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	194000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	169000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	114847000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	115048000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5970373	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5946315	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5946315	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	431998000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	430678000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-517000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-516000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-453403000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-438178000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-21921000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8015000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	92926000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	107033000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	866000	usd
CY2024Q1	us-gaap	Revenues Revenues	1528000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	903000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	941000	usd
CY2024Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	574000	usd
CY2023Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1071000	usd
CY2024Q1	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	0	usd
CY2023Q1	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	370000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	1477000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	2382000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	51000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-445000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12387000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4165000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3791000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5260000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1008000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	16178000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	10433000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16127000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10878000	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	683000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	283000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	24000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-304000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	245000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-253000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15223000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10544000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-15225000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10544000	usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.53
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.53
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.87
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6020992	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6020992	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5623430	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5623430	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-15225000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10544000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	173000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-37000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	136000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15226000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10408000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8015000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-15225000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1286000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	17000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-21921000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125324000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10544000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	136000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-9199000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	235000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	106028000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-15225000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10544000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	446000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	601000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1008000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1286000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-9199000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	24000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-304000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1125000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2024Q1	hlg	Non Cash Lease Expense NonCashLeaseExpense	458000	usd
CY2023Q1	hlg	Non Cash Lease Expense NonCashLeaseExpense	400000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	119000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	677000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1331000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1497000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-133000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	458000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1147000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1786000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	135000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3084000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1308000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	705000	usd
CY2024Q1	hlg	Increase Decrease In Contract Loss Provisions IncreaseDecreaseInContractLossProvisions	-824000	usd
CY2023Q1	hlg	Increase Decrease In Contract Loss Provisions IncreaseDecreaseInContractLossProvisions	-77000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-541000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	345000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14313000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24132000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	150000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	527000	usd
CY2024Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	44520000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10000000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	62300000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9850000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	17253000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	248000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	248000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4480000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6631000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64215000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47874000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59735000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41243000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58235000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39215000	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	528000	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1000000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59735000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41243000	usd
CY2024Q1	hlg	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	51000	usd
CY2023Q1	hlg	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	76000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	65000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	56000	usd
CY2024Q1	us-gaap	Investments And Cash InvestmentsAndCash	60700000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58200000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	2500000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-15200000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14300000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and the accompanying notes. Despite our intention to establish accurate estimates and reasonable assumptions, actual results could differ materially from such estimates and assumptions.</span></div>
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	954000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	866000	usd
CY2024Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	574000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1071000	usd
CY2024Q1	us-gaap	Revenues Revenues	1528000	usd
CY2023Q1	us-gaap	Revenues Revenues	1937000	usd
CY2023Q1	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	400000	usd
CY2024Q1	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	0	usd
CY2024Q1	hlg	Loss On Contracts Amortization LossOnContractsAmortization	800000	usd
CY2023Q1	hlg	Loss On Contracts Amortization LossOnContractsAmortization	400000	usd
CY2024Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	usd
CY2023Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	37700000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.28
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1697000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	954000	usd
CY2024Q1	us-gaap	Grants Receivable Current GrantsReceivableCurrent	4197000	usd
CY2023Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	3623000	usd
CY2024Q1	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	310000	usd
CY2023Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	309000	usd
CY2024Q1	hlg	Receivables Gross Current ReceivablesGrossCurrent	6204000	usd
CY2023Q4	hlg	Receivables Gross Current ReceivablesGrossCurrent	4886000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	202000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	207000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	6002000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	4679000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	17008000	usd
CY2024Q1	hlg	Contract With Customer Liability Increase For Deferred Revenue Additions ContractWithCustomerLiabilityIncreaseForDeferredRevenueAdditions	1836000	usd
CY2024Q1	hlg	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	533000	usd
CY2024Q1	hlg	Contract With Customer Liability Recognition Of Consideration Payable Excluding Opening Balance ContractWithCustomerLiabilityRecognitionOfConsiderationPayableExcludingOpeningBalance	51000	usd
CY2024Q1	hlg	Contract With Customer Liability Other Excluding Opening Balance ContractWithCustomerLiabilityOtherExcludingOpeningBalance	-13000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18247000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent	2491000	usd
CY2024Q1	hlg	Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax Current DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	2491000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent	12387000	usd
CY2023Q4	hlg	Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax Current DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent	1000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	12386000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1463000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1870000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2751000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2424000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	0	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	53000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2391000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2391000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1823000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1956000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10543000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10368000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5211000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4791000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5332000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5577000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	400000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	600000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	118000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1084000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1291000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1913000	usd
CY2024Q1	hlg	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	4532000	usd
CY2023Q4	hlg	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	3658000	usd
CY2024Q1	hlg	Inventory In Transit InventoryInTransit	0	usd
CY2023Q4	hlg	Inventory In Transit InventoryInTransit	29000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1856000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1792000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	419000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	431000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8216000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8907000	usd
CY2023Q2	hlg	Share Purchase Right Plan Number Of Declared Dividend In Shares SharePurchaseRightPlanNumberOfDeclaredDividendInShares	1	shares
CY2023Q2	hlg	Share Purchase Right Plan Beneficial Ownership Acquired Percentage SharePurchaseRightPlanBeneficialOwnershipAcquiredPercentage	0.125
CY2023Q2	hlg	Share Purchase Right Plan Investors Beneficial Ownership Acquired Percentage SharePurchaseRightPlanInvestorsBeneficialOwnershipAcquiredPercentage	0.20
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-15225000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10544000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5952672	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	5561060	shares
CY2024Q1	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	68320	shares
CY2023Q1	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	62370	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6020992	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5623430	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6020992	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5623430	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.53
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.53
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.87
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.35
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.35
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1286000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-9199000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1286000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-9199000	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd

Files In Submission

Name	View Source	Status
0001840292-24-000022-index-headers.html	Edgar Link	pending
0001840292-24-000022-index.html	Edgar Link	pending
0001840292-24-000022.txt	Edgar Link	pending
0001840292-24-000022-xbrl.zip	Edgar Link	pending
ex311-2024q110xq.htm	Edgar Link	pending
ex312-2024q110xq.htm	Edgar Link	pending
ex321-2024q110xq.htm	Edgar Link	pending
ex322-2024q110xq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hlg-20240331.htm	Edgar Link	pending
hlg-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
hlg-20240331_cal.xml	Edgar Link	unprocessable
hlg-20240331_def.xml	Edgar Link	unprocessable
hlg-20240331_lab.xml	Edgar Link	unprocessable
hlg-20240331_htm.xml	Edgar Link	completed
hlg-20240331_pre.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HLGN
Heliogen, Inc. Stock $hlgn

2024 Q2 Form 10-Q Financial Statement

#000184029224000022 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLGN Heliogen, Inc. Stock $hlgn

2024 Q2 Form 10-Q Financial Statement

#000184029224000022 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLGN
Heliogen, Inc. Stock $hlgn